Cathy Gwin
Senior Director, Communications
News
Media Contact
NTI Endorses Biosecurity Modernization and Innovation Act of 2026
NTI endorses the bipartisan Biosecurity Modernization and Innovation Act of 2026, led by Senators Tom Cotton (R-AR) and Amy Klobuchar (D-MN). This bill creates an important opportunity to incentivize a safe and secure U.S. bioeconomy through strengthened biosecurity policy.
New NTI Framework Tackles Misuse Risks in AIxBio Tools
New NTI | bio paper calls on tool developers and other AIxBio stakeholders to implement a managed access approach—allowing only validated users to access those biological AI models that contribute to biosecurity risks—to help reduce the risk that such tools will be deliberately misused to cause harm.
Introducing the Winners of the 2025 Next Generation for Biosecurity Competition
Students and early-career professionals from 19 countries across five continents entered the 2025 competition. The challenge called for innovative papers on how to define “biological weapons” in today’s ever evolving biothreat landscape.
NTI at the Biological Weapons Convention: Urging Collective Action to Reduce Biological and AI Risks
NTI’s Global Biological Policy and Programs team will host two side events at the Sixth Session of the Working Group on the Strengthening of the Biological Weapons Convention (BWC).
HHS Cancellation of Funding for mRNA Vaccines is a Dangerous Mistake that Puts Millions of Lives at Risk
A statement by Jaime M. Yassif, PhD, vice president, NTI Global Biological Policy and Programs.
B-roll North Korean Nuclear Test
B-Roll IRAN Natanz Enrichment Complex
B-roll Rattehalli Materials Plant - India
Stay Informed
Sign up for our newsletter to get the latest on nuclear and biological threats.
